Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Five Reputable Sauna Room Manufacturers in China 2026: Leading Global Wellness Sauna Manufacturing
EIN Presswire
Delivering Premium Sauna Solutions for Global Wellness and Hospitality Markets CALIFORNIA, CA, UNITED STATES, June 17, 2026 /EINPresswire.com/ -- As the international wellness market expands, buyers are increasingly turning to China for reliable...
Univar Solutions Expands Exclusive Beauty, Personal Care, and Pharmaceutical Ingredients Partnership with American Distilling in EMEA
GlobeNewswire, Inc.
ROTTERDAM, The Netherlands, June 17, 2026 (GLOBE NEWSWIRE) -- Univar Solutions B.V., a subsidiary of Univar Solutions LLC (“Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals,...
Aplagon Announces EUR 5 Million Financing to Broaden Phase 2 Trials of its APAC Therapy in Thrombo-Inflammatory Diseases
GlobeNewswire, Inc.
HELSINKI, June 16, 2026 (GLOBE NEWSWIRE) -- Aplagon, a clinical-stage biotechnology company developing APAC, a first-in-class antiplatelet and anticoagulant therapy for treating thrombo-inflammatory diseases, today announced the close of a EUR 4.8...
As Home Sauna Demand Rises, Two Decades of Research Link Regular Sauna Use to Better Heart Health
EIN Presswire
SaunaHeaters.com points homeowners to the long-running Finnish studies behind the wellness trend, and to what the research does and does not show SAN FRANCISCO, CA, UNITED STATES, June 11, 2026 /EINPresswire.com/ -- Americans are bringing the...
Finnish Health Agency Urges Age Restriction on Energy Drink Sales
MENAFN
(MENAFN) Finland’s health authority has recommended prohibiting the sale of energy drinks to anyone under the age of 18, according to reports.
Urteste S.A. enrolls the first patient in the Panuri test clinical study
GlobeNewswire, Inc.
Urteste S.A. enrolls the first patient in the Panuri test clinical study Gdańsk, Poland – 10 June 2026 – Urteste S.A. (Warsaw Stock Exchange: URT), a company developing innovative technology for the detection of cancer based on urine samples, has...
Finland Urges Ban on Energy Drink Sales to Teens Under 18
MENAFN
(MENAFN) Finland's leading public health authority is calling for an immediate ban on energy drink sales to minors, sounding the alarm over a deeply entrenched consumption habit among the country's youth.
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
GlobeNewswire, Inc.
CHICAGO, June 04, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its proprietary brand, Sky Premium Life, is now...
Minister Butler highlights value of Lived Experience in Irish health policy development and service improvement at European Patient Forum
Government of Ireland
Minister for Mental Health, Mary Butler TD is today representing Ireland at the Patient Engagement Open Forum (PEOF) in Seville, Spain, a high-level European policy event focused on patient involvement in healthcare.
Aplagon Announces Review Publication on APAC, a First-in-Class Dual-Action Antithrombotic to Treat Unmet Clinical Needs in Thromboinflammatory Diseases
GlobeNewswire, Inc.
HELSINKI, June 01, 2026 (GLOBE NEWSWIRE) -- Aplagon, a clinical-stage biotech developing first-in-class therapies for thromboinflammatory diseases, today announced the comprehensive publication of an invited review article in Arteriosclerosis,...
Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 30 MAY 2026 at 21:30 EEST Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours Data presented at 2026 ASCO® Annual Meeting show ODM-212...
Public Health Command Europe Hosts 71st International Military Veterinary Exchange
DVIDS - Georgia
Garmisch- Partenkirchen, Germany --- Public Health Command Europe recently hosted the 71st International Military Veterinary Exchange, bringing together nearly 100 veterinary leaders from 18 Allied and Partner nations to strengthen alliances,...
Finland Classifies Andes Hantavirus as Public Health Risk
MENAFN
(MENAFN) Finland has officially designated the Andes strain of hantavirus a "public health risk" following reports of possible exposure within the country, a public broadcaster reported Tuesday — a classification that unlocks compensation for...
Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 21 MAY 2026 at 10:30 EEST Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting First clinical data from the Phase 1/2 TEADES trial of...
Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease
GlobeNewswire, Inc.
Herantis Pharma Plc – Press release Indivi’s digital biomarker platform is designed to enable earlier and more sensitive detection of treatment-related changes Improved sensitivity and reduced variability may support more efficient clinical...
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
GlobeNewswire, Inc.
SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, and ŌURA, maker of the world’s leading smart ring, today announced they are...
Finland Causations of Increasing Strain on Country’s Public Finances
MENAFN
(MENAFN) Finland’s finance minister Riikka Purra has raised concerns about increasing strain on the country’s public finances, shortly after the government introduced a long-term fiscal plan that pairs higher military assistance to Ukraine with...
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
GlobeNewswire, Inc.
Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at its European center of excellence Tel Aviv Sourasky...
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
GlobeNewswire, Inc.
SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference grew substantially compared to...
Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 12 MAY 2026 at 10:30 EEST Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs Orion Corporation today announced...
Sign up for:
Health Daily Finland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.